Patents by Inventor Eric Culbert

Eric Culbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human antibodies and binding fragments thereof to tenascin
    Patent number: 11332520
    Abstract: The present disclosure relates to antibodies and binding fragments to a Tenascin, in particular the FBG domain of a Tenascin, which are potentially less immunogenic than the parent antibody. The disclosure also relates to compositions comprising the antibody or binding fragment and use of any one of the same for diagnosis, prognosis and/or treatment of disorders such as those associated with chronic inflammation. The disclosure further provides methods of making the antibodies.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: May 17, 2022
    Assignee: STERLING IP LIMITED
    Inventors: Patrick Hextall, Kim Suzanne Midwood, Eric Culbert
  • HUMAN ANTIBODIES AND BINDING FRAGMENTS THEREOF TO TENASCIN
    Publication number: 20200223910
    Abstract: The present disclosure relates to antibodies and binding fragments to a Tenascin, in particular the FBG domain of a Tenascin, which are potentially less immunogenic than the parent antibody. The disclosure also relates to compositions comprising the antibody or binding fragment and use of any one of the same for diagnosis, prognosis and/or treatment of disorders such as those associated with chronic inflammation. The disclosure further provides methods of making the antibodies.
    Type: Application
    Filed: February 10, 2017
    Publication date: July 16, 2020
    Inventors: Patrick HEXTALL, Kim Suzanne MIDWOOD, Eric CULBERT
  • Tenascin Epitope and Antibodies Thereto
    Publication number: 20190225680
    Abstract: The present disclosure relates to a neutralising epitope for Tenascin-C, and binding domains specific thereto, for example antibodies or binding fragments thereof, pharmaceutical compositions comprising the same and use of said antibodies, binding fragments or composition in treatment, in particular the treatment of an inflammatory disorder.
    Type: Application
    Filed: September 29, 2017
    Publication date: July 25, 2019
    Applicant: Nascient Ltd
    Inventors: Kim Midwood, Eric Culbert, Patrick John Hextall